T.E.A.M. Feasibility and Efficacy Study 2.0 (TEAM)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03694106 |
Recruitment Status :
Active, not recruiting
First Posted : October 3, 2018
Last Update Posted : March 3, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
T.E.A.M. psychotherapy was developed by one of the founders of cognitive therapy, David Burns and builds on traditional CBT with an emphasis on T = Testing, E = Empathy, A = Agenda Setting (assessing and building motivation) and M = Methods (including cognitive and behavioral methods). Because TEAM therapy is a data-driven therapy, its delivery hinges on the use of symptom measures and measures of the therapeutic alliance at every session with every patient. These measures are now available for collection thru computerized forms, making their collection and review considerably more accessible and efficient for the patient and therapist.
The following hypotheses will be tested:
- TEAM psychotherapy using computerized measurement collection is safe and feasible.
- TEAM psychotherapy using computerized measurement collection shows evidence of efficacy by exploratory non inferiority testing compared to benchmark studies with similar psychotherapeutic modalities
- Evidence for efficacy is strong enough to justify pursuit of an experimental randomized controlled clinical trial of TEAM therapy for major depressive disorder versus treatment as usual.
Condition or disease | Intervention/treatment |
---|---|
Depression, Anxiety | Behavioral: TEAM PSYCHOTHERAPY |
Study Type : | Observational |
Estimated Enrollment : | 80 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Feasility Pilot of T.E.A.M. Psychotherapy Using Electronic Capture of Before and After Therapy Measures. |
Actual Study Start Date : | April 15, 2019 |
Estimated Primary Completion Date : | November 1, 2022 |
Estimated Study Completion Date : | November 1, 2023 |

- Behavioral: TEAM PSYCHOTHERAPY
Patients data will be collected from the first to the final psychotherapy session as performed normally by TEAM trained clinicians. The treatment-as-usual includes therapy sessions of 50 to 110minutes long, typically once or twice per week for an average of 8-12 sessions. Treatment as usual by these clinicians includes the use of psychological symptoms survey immediately before and after each psychotherapy session. Typically patients will fill out these surveys in the clinic's waiting area before and after each session.
- NIH PROMIS 4 item depression questionnaire [ Time Frame: 9 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- 1. Cognitive functioning at a level and ability to use an electronic tool. 2. Demonstration of decisional capacity in order to participate in psychotherapy.
Exclusion Criteria:
1. Under age 18 3. Providers: not TEAM certified at a level 3 or above 2. Patients: Non-fluent English speakers. The tool for now is only available in English
-

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03694106
United States, California | |
Feeling Good Institute | |
Mountain View, California, United States, 94040 |
Principal Investigator: | Maor Katz, MD | Feeling Good Institute | |
Principal Investigator: | Alex Clarke, MD | Feeling Good Institute |
Responsible Party: | Alex Clarke, Director of Research and Development, Feeling Good Institute |
ClinicalTrials.gov Identifier: | NCT03694106 |
Other Study ID Numbers: |
41809 |
First Posted: | October 3, 2018 Key Record Dates |
Last Update Posted: | March 3, 2020 |
Last Verified: | February 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Depression Behavioral Symptoms |